Real-world dosing of omalizumab for chronic spontaneous urticaria

被引：0
|
作者：
McIntyre, Amanda P. [1 ]
Viswanathan, Ravi K. [1 ]
Moss, Mark H. [1 ]
Mathur, Sameer K. [1 ]
机构：
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Allergy Pulm & Crit Care, Madison, WI 53706 USA
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 124卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：211 / 212
页数：3
相关论文
共 50 条
  • [21] Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of "real-world' evidence
    Bernstein, Jonathan A.
    Kavati, Abhishek
    Tharp, Michael D.
    Ortiz, Benjamin
    MacDonald, Karen
    Denhaerynck, Kris
    Abraham, Ivo
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (04) : 425 - 448
  • [22] OMALIZUMAB TREATMENT IS EFFECTIVE FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA DESPITE DELAY IN TREATMENT INITIATION: A REAL-WORLD STUDY
    Rajput, Y.
    Thomas, C.
    Hetherington, J.
    Hoskin, B.
    Wrest, E.
    Holden, M.
    Bernstein, J. A.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S587 - S587
  • [23] REAL-WORLD TREATMENT PATTERNS OF OMALIZUMAB IN CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) PATIENTS IN THE UNITED STATES
    Eghrari-Sabet, J.
    Sher, E.
    Lefebvre, P.
    Pilon, D.
    Zhdanava, M.
    Balp, M.
    Kavati, A.
    Ortiz, B.
    Bernstein, J.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S42 - S42
  • [24] Omalizumab in Children and Adolescents with Chronic Urticaria: A 16 Week Real-World Study
    Song, Xiaoting
    Maurer, Marcus
    Chen, Yudi
    Yu, Miao
    Zhao, Zuotao
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB26 - AB26
  • [25] Addition of omalizumab to antihistamine treatment in chronic urticaria A real-world study in China
    Chen, Yu-Di
    Maurer, Marcus
    Yu, Miao
    Tu, Ping
    Zhao, Zuo-Tao
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (02) : 217 - 219
  • [26] Cost-effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria
    Denman, Sarah
    Smith, Helin
    Arumugakani, Gururaj
    Mistry, Anoop
    Savic, Sinisa
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) : 2002 - 2005
  • [27] A Real-World Analysis of Relapse Rate and Efficacy of a Restricted Monthly Dose of Omalizumab in Recalcitrant Chronic Spontaneous Urticaria in India
    Sardana, Kabir
    Dixit, Niharika
    Arora, Pooja
    [J]. INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (05) : 835 - 837
  • [28] Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: Meta-Analysis of "real-world" evidence
    Tharp, M. D.
    Lee, C. S.
    Mac Donald, K. M.
    Denhaerynck, K.
    Abraham, I. L.
    Ortiz, B.
    Kavati, A.
    Bernstein, J. A.
    [J]. ALLERGY, 2018, 73 : 224 - 224
  • [29] Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study
    Hide, Michihiro
    Fukunaga, Atsushi
    Suzuki, Takayuki
    Nakamura, Noriko
    Kimura, Mine
    Sasajima, Takayoshi
    Kiriyama, Junna
    Igarashi, Atsuyuki
    [J]. ALLERGOLOGY INTERNATIONAL, 2023, 72 (02) : 286 - 296
  • [30] Omalizumab in chronic spontaneous urticaria
    Martin Marques, Marta
    De Dios Lopez, Anna
    Jornet Montana, Sonia
    Sanchez Parada, Lucia
    Lopez Broseta, Pilar Ana
    del Estal Jimenez, Jorge
    Canela Subirada, Montserrat
    Canadell Vilarrasa, Laura
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 223 - 223
12345